Umeclidinium bromide (UMEC)
Showing 1 - 25 of 313
Pulmonary Disease, Chronic Obstructive Trial (FF/UMEC/VI)
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- (no location specified)
Sep 7, 2022
Using US Medical and Pharmacy Claim Records to Compare Resource
Completed
- Pulmonary Disease, Chronic Obstructive
- Trelegy Ellipta
- +3 more
-
Eden Prairie, MinnesotaOptum
Mar 11, 2022
Pulmonary Disease, Chronic Obstructive Trial (FF/UMEC/VI, ELLIPTA)
Not yet recruiting
- Pulmonary Disease, Chronic Obstructive
- FF/UMEC/VI
- ELLIPTA
- (no location specified)
Aug 15, 2022
Pulmonary Disease, Chronic Obstructive Trial in Poland, Russian Federation, United States (FF/UMEC/VI, Tiotropium,
Completed
- Pulmonary Disease, Chronic Obstructive
- FF/UMEC/VI
- +7 more
-
Andalusia, Alabama
- +71 more
Jul 13, 2021
Pulmonary Disease, Chronic Obstructive Trial in China, Korea, Republic of (Umeclidinium bromide, Placebo)
Completed
- Pulmonary Disease, Chronic Obstructive
- Umeclidinium bromide
- Placebo
-
Guangzhou, Guangdong, China
- +25 more
Jun 12, 2020
Based on Medical Records That Looks at Duration of Use of Two
Completed
- Pulmonary Disease, Chronic Obstructive
- Olodaterol/Tiotropium Bromide
- Umeclidinium/ Vilanterol
-
New York, New YorkAetion Inc.
Nov 12, 2021
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (budesonide/formoterol, albuterol/salbutamol, FF/UMEC/VI)
Completed
- Pulmonary Disease, Chronic Obstructive
- budesonide/formoterol
- +9 more
-
Gold River, California
- +56 more
Oct 7, 2020
Pulmonary Disease, Chronic Obstructive Trial in Czechia, Germany, United States (budesonide/formoterol, albuterol/salbutamol,
Completed
- Pulmonary Disease, Chronic Obstructive
- budesonide/formoterol
- +9 more
-
Mobile, Alabama
- +56 more
Oct 7, 2020
Pulmonary Disease, Chronic Obstructive Trial in Waterbury, Charlotte, Layton (Inhaled corticosteroids/long-acting
Withdrawn
- Pulmonary Disease, Chronic Obstructive
- Inhaled corticosteroids/long-acting beta2-adrenergic/long-acting muscarinic receptor antagonists
- Fluticasone furoate/umeclidinium/vilanterol
-
Waterbury, Connecticut
- +2 more
Apr 21, 2020
COPD, Non Small Cell Lung Cancer Trial in Seoul (Vilanterol and Umeclidinium Bromide, Placebo)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Non Small Cell Lung Cancer
- Vilanterol and Umeclidinium Bromide
- Placebo
-
Seoul, Korea, Republic ofSamsung Medical Center
Apr 1, 2021
Study to Evaluate the Risk of Cardiovascular Endpoints
Completed
- Pulmonary Disease, Chronic Obstructive
- Aclidinium bromide
- Other COPD medication
-
London, United KingdomClinical Practice Research Datalink
Jan 30, 2023
Asthma Trial in Worldwide (FF/UMEC/VI (100/31.25/25) mcg, FF/UMEC/VI (100/62.5/25) mcg, FF/UMEC/VI (200/31.25/25) mcg)
Completed
- Asthma
- FF/UMEC/VI (100/31.25/25) mcg
- +10 more
-
Birmingham, Alabama
- +408 more
Feb 26, 2021
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (FF/UMEC/VI, Inhaled Corticosteroid, LAMA)
Completed
- Pulmonary Disease, Chronic Obstructive
- FF/UMEC/VI
- +4 more
-
Aschaffenburg, Bayern, Germany
- +142 more
Aug 19, 2020
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (FF/UMEC/VI, FF/VI, UMEC)
Completed
- Pulmonary Disease, Chronic Obstructive
- FF/UMEC/VI
- +4 more
-
La Plata, Buenos Aires, Argentina
- +126 more
May 3, 2019
Pulmonary Disease, Chronic Obstructive Trial in Worldwide (UMEC/VI 62.5/25 mcg via ELLIPTA, UMEC 62.5 mcg via ELLIPTA,
Completed
- Pulmonary Disease, Chronic Obstructive
- UMEC/VI 62.5/25 mcg via ELLIPTA
- +4 more
-
Phoenix, Arizona
- +212 more
Mar 2, 2020
COPD Trial in India, United States (Test Product - Tiotropium Bromide Inhalation Powder 18 mcg, Spiriva Handihaler (Tiotropium
Active, not recruiting
- COPD
- Test Product - Tiotropium Bromide Inhalation Powder 18 mcg
- +2 more
-
Los Angeles, California
- +32 more
Aug 3, 2023
Succinylcholine, Myofibrillation Trial in Yangzhou (rocuronium)
Enrolling by invitation
- Succinylcholine
- Myofibrillation
-
Yangzhou, Jiangsu, Chinathe Affiliated Hospital of Yangzhou University, Yangzhou Univers
Jun 10, 2023
Asthma, COPD Trial in Manchester (CHF6366, Placebo CHF6366, umeclidinium bromide and vilanterol trifenatate)
Completed
- Asthma
- Chronic Obstructive Pulmonary Disease
- CHF6366
- +2 more
-
Manchester, United KingdomMedicines Evaluation Unit
May 5, 2020
COPD Trial in Guangzhou (Tiotropium Bromide Combined With Odaterol)
Recruiting
- Chronic Obstructive Pulmonary Disease
- Tiotropium Bromide Combined With Odaterol
-
Guangzhou, Guangdong, ChinaGuangzhou Institute of Respiratory Diseases
Oct 19, 2022
Primary Axillary Hyperhidrosis Trial in Rogers (Sofpironium Bromide Gel, 15%)
Completed
- Primary Axillary Hyperhidrosis
- Sofpironium Bromide Gel, 15%
-
Rogers, ArkansasNorthwest Arkansas Clinical Trials Center
Dec 19, 2022